Rudy A. Mazzocchi has over 30 years of Senior Executive Management, Technology and Intellectual Property Development, and Financing Experience (institutional, venture, private and public) in the Med-tech, Biotech, and Biopharma industries. As a founder of over a dozen Healthcare companies, he has developed and commercialized multiple technologies ranging from diagnostics to implantable medical devices, requiring demanding clinical validation and regulatory reviews, including FDA Clearance, CE Mark, and International Regulatory Approvals.
As Chairman/CEO of AGENTIX Biopharma Corp., he concurrently serves as Acting-CEO of Berkshire Biomedical, Co-Founder/Vice Chairman of the BioMedX Group, Executive Chairman or Independent Director of several private and public, early and growth-stage Companies, and Senior Advisor to a variety of International Corporations seeking global expansion and/or access to U.S. public markets. Rudy previously served as Executive Chairman of Establishment Labs (NASDAQ:ESTA) and Independent Director of Greatbatch/Integer Medical (NYSE:ITGR).
He is the recipient of the Technology Leadership Award, the Businessman of the Year Award, the Ernst & Young Entrepreneur of the Year Award in Healthcare, and Global Entrepreneur of the Year Award. He has also authored more than 100 patents, three published award-winning novels and a top-selling business book on Entrepreneurism.
Listen to rudy at the FTE2020 Investor Summit